On June 17,2014, the United States District Court for the Central District of California appointed KSF as sole lead counsel in Chen v. CytRx Corporation, et al., 2:14-cv-01956-GHK, a securities fraud class action brought on behalf of all persons who purchased or otherwise acquired the publicly traded common stock of CytRx between November 20, 2013 and March 13, 2014.